Delivery Order SPE2DB24D1021-SPE2DB25FESAW

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,018.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a critical care medication, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $1,129.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product, with a performance period ending on May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VALTOCO 10 MG NASAL SPRAYS. The $1,439.65 firm fixed-price delivery order contract has a completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $3,558.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VALTOCO 10 MG nasal sprays, with a completion date of November 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,149.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, a medical product, with a completion date of June 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of pharmaceutical products, specifically VALTOCO 10 MG nasal sprays. The contract has a ceiling value of $1,672.48 and is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award, which...
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYA1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,394.78 delivery order is for the supply of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) type, with an ultimate completion date of October 24, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, with a ceiling value of $3,953.59 and a period of performance through June 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This federal contract award is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of the prime contractor Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at $1,253.65, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price valued at $10,918.60 and a completion date of March 27, 2024. The contract is for the delivery of VALTOCO 5 MG NASAL SPRAYS, a specialty pharmaceutical product. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FESAW
    Delivery Order

This federal contract award, valued at $1,254.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, a critical medical product. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's extensive experience and capabilities in the federal healthcare supply chain make it a key vendor for DLA and other government agencies.

Generated 5/20/25, 2:10 PM